Company Profile
IDEAYA Biosciences Stock Price, News & Analysis
Company overview
Business overview
IDEAYA Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, IDEAYA Biosciences is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
IDEAYA Biosciences follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, IDEAYA Biosciences sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Why the stock is moving
IDYA is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Future catalysts
IDEAYA's catalysts are darovasertib, IDE397, and any combination-data update that shows the precision-oncology platform can support more than one real shot on goal. The company still needs the next readout to show that the platform can translate into repeatable clinical value.
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
- 02
IDEAYA Biosciences Reports First Quarter 2026 Financial Results and Provides Business Update
Source: IDEAYA Biosciences
- 03
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Source: IDEAYA Biosciences
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.